Liu, Y., Jeng, W., Peng, C., Chien, R., & Liaw, Y. (2024). Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals. Wiley. https://doi.org/10.1111/apt.17880
Chicago-Zitierstil (17. Ausg.)Liu, Yen‐Chun, Wen‐Juei Jeng, Chien‐Wei Peng, Rong‐Nan Chien, und Yun‐Fan Liaw. Higher End‐of‐treatment HBsAg Levels Is Associated with Later Onset but Not Severe Relapse in HBeAg‐negative Chronic Hepatitis B Patients Stopping Antivirals. Wiley, 2024. https://doi.org/10.1111/apt.17880.
MLA-Zitierstil (9. Ausg.)Liu, Yen‐Chun, et al. Higher End‐of‐treatment HBsAg Levels Is Associated with Later Onset but Not Severe Relapse in HBeAg‐negative Chronic Hepatitis B Patients Stopping Antivirals. Wiley, 2024. https://doi.org/10.1111/apt.17880.